ArticleScientific reports2025
EEG glasses for real-time brain electrical activity monitoring.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Wearable devices are becoming a cornerstone for personalized and long-term health monitoring, enabling early intervention and data-driven medical decisions. In this work, we present e-Glass, a state-of-the-art smart wearable device that enables unobtrusive real-time electroencephalography (EEG) monitoring. Our evaluation shows that e-Glass adheres to the established international guidelines for clinical EEG recordings. Moreover, the acquired data presents a Pearson's correlation of 0.93 relative to recordings obtained from the Biopac research-grade EEG system . The proposed EEG acquisition device concept is evaluated in two application domains: epileptic seizure detection and cognitive workload monitoring (CWM). First, we present a lightweight edge machine-learning scheme, designed specifically for e-Glass, achieving overall sensitivity of 64% (100% sensitivity in 11 out of 24 subjects) and 2.35 false-alarms per day, when tested on 982.9 hours of EEG data from the CHB-MIT dataset. Similarly, an CWM strategy with e-Glass reaches an accuracy of 74.5% on unseen data. These results demonstrate that e-Glass is capable of unobtrusive and real-time subject monitoring in outpatient conditions, not only in epileptic seizure detection but also in monitoring the subject's cognitive state.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.